Factors associated with local failure after stereotactic radiation to the surgical bed of patients with a single breast cancer metastasis - Takeaways - MDSpire

Factors associated with local failure after stereotactic radiation to the surgical bed of patients with a single breast cancer metastasis

  • By

  • Ory Haisraely

  • Marcia L. Jaffe

  • Yaacov R Lawrence

  • Zvi Symon

  • Anton Whol

  • Thaila Kaisman-Elbaz

  • Zvi R Cohen

  • Alicia Taliansky

  • Orit Kaidar-Person

  • April 22, 2025

  • 0 min

Share

  • 1

    Metastatic breast cancer is increasingly associated with brain metastases due to improved survival rates in breast cancer patients.

  • 2

    Local therapy for breast cancer brain metastases has shifted towards stereotactic radiation, reducing the use of whole brain radiation.

  • 3

    Factors influencing local control after stereotactic radiation include tumor histology, molecular subtype, and surgical cavity characteristics.

  • 4

    The study evaluated 62 patients with single breast cancer brain metastasis treated with stereotactic radiation post-craniotomy.

  • 5

    Most patients in the cohort were HER2 positive, with a significant portion having stable receptor status after treatment.

Original Source(s)

Factors associated with local failure after stereotactic radiation to the surgical bed of patients with a single breast cancer metastasis

  • by Ory Haisraely, Marcia L. Jaffe, Yaacov R Lawrence, Zvi Symon, Anton Whol, Thaila Kaisman-Elbaz, Zvi R Cohen, Alicia Taliansky, Orit Kaidar-Person

  • April 22, 2025

Related Content

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

Combination of Albumin-Bound Paclitaxel and Cisplatin with Radiotherapy for Locally Advanced Oesophageal Squamous Cell Carcinoma: Results from a Phase II Single-Arm Study

Will Circulating Tumor DNA Help Predict HPV-Related Throat Cancer?

A Keck Medicine of USC head and neck surgeon discusses circulating HPV DNA as a biomarker that could help make more individualized treatment decisions.

  • by

  • March 24, 2026

  • 5 min